Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1967 1
1969 2
1971 1
1972 2
1973 2
1974 1
1975 4
1977 3
1978 1
1979 3
1982 4
1983 3
1984 1
1985 2
1986 1
1987 7
1988 19
1989 21
1990 8
1991 16
1992 10
1993 20
1994 22
1995 15
1996 28
1997 25
1998 25
1999 21
2000 19
2001 20
2002 25
2003 23
2004 31
2005 25
2006 31
2007 32
2008 11
2009 19
2010 19
2011 23
2012 23
2013 26
2014 31
2015 28
2016 27
2017 24
2018 20
2019 19
2020 21
2021 26
2022 23
2023 27
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

808 results

Results by year

Filters applied: . Clear all
Page 1
Ampullary cancer: an overview.
Ahn DH, Bekaii-Saab T. Ahn DH, et al. Am Soc Clin Oncol Educ Book. 2014:112-5. doi: 10.14694/EdBook_AM.2014.34.112. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857067 Free PMC article. Review.
Celiac disease.
Green PH, Cellier C. Green PH, et al. N Engl J Med. 2007 Oct 25;357(17):1731-43. doi: 10.1056/NEJMra071600. N Engl J Med. 2007. PMID: 17960014 Review. No abstract available.
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.
Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL. Isaji S, et al. Pancreatology. 2018 Jan;18(1):2-11. doi: 10.1016/j.pan.2017.11.011. Epub 2017 Nov 22. Pancreatology. 2018. PMID: 29191513 Free article.
This statement was developed to promote international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC) which was adopted by the National Comprehensive Cancer Network (NCCN) in 2006, but which has changed yearly and become more …
This statement was developed to promote international consensus on the definition of borderline resectable pancreatic ductal adenocarcino
Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.
Burasakarn P, Higuchi R, Nunobe S, Kanaji S, Eguchi H, Okada KI, Fujii T, Nagakawa Y, Kanetaka K, Yamashita H, Yamada S, Kuroda S, Aoyama T, Akahori T, Nakagawa K, Yamamoto M, Yamaue H, Sho M, Kodera Y; Japan Duodenal Cancer Guideline Committee. Burasakarn P, et al. Int J Clin Oncol. 2021 Mar;26(3):450-460. doi: 10.1007/s10147-020-01840-5. Epub 2021 Jan 1. Int J Clin Oncol. 2021. PMID: 33386555 Review.
It is well known that surgery is the mainstay treatment for duodenal adenocarcinoma. However, the optimal extent of surgery is still under debate. ...All studies comparing LR and pancreatoduodenectomy for patients with duodenal adenocarcinoma were sele …
It is well known that surgery is the mainstay treatment for duodenal adenocarcinoma. However, the optimal extent of surgery is …
Neoadjuvant Therapy for Duodenal and Ampullary Adenocarcinoma: A Systematic Review.
Zhang C, Lizalek JM, Dougherty C, Westmark DM, Klute KA, Reames BN. Zhang C, et al. Ann Surg Oncol. 2024 Feb;31(2):792-803. doi: 10.1245/s10434-023-14531-y. Epub 2023 Nov 11. Ann Surg Oncol. 2024. PMID: 37952021 Review.
BACKGROUND: The role of systemic therapy in the management of ampullary (AA) and duodenal adenocarcinoma (DA) remains poorly understood. This study sought to synthesize current evidence supporting the use of neoadjuvant therapy (NAT) in AA and DA. ...
BACKGROUND: The role of systemic therapy in the management of ampullary (AA) and duodenal adenocarcinoma (DA) remains poorly u …
Current status of molecular diagnostic approaches using liquid biopsy.
Takahashi K, Takeda Y, Ono Y, Isomoto H, Mizukami Y. Takahashi K, et al. J Gastroenterol. 2023 Sep;58(9):834-847. doi: 10.1007/s00535-023-02024-4. Epub 2023 Jul 20. J Gastroenterol. 2023. PMID: 37470859 Free PMC article. Review.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers, and developing an efficient and reliable approach for its early-stage diagnosis is urgently needed. ...This review discusses the current diagnostic approaches and clinical application …
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers, and developing an efficient and reliable ap …
Hereditary gastric cancer.
Carneiro F. Carneiro F. Pathologe. 2012 Nov;33 Suppl 2:231-4. doi: 10.1007/s00292-012-1677-6. Pathologe. 2012. PMID: 23052347 Review.
In 2011, a new hereditary gastric cancer syndrome was identified: gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). GAPPS is a unique gastric polyposis syndrome with a significant risk of gastric adenocarcinoma, characterized by the autosomal dom …
In 2011, a new hereditary gastric cancer syndrome was identified: gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS …
Progress in the Treatment of Small Intestine Cancer.
Symons R, Daly D, Gandy R, Goldstein D, Aghmesheh M. Symons R, et al. Curr Treat Options Oncol. 2023 Apr;24(4):241-261. doi: 10.1007/s11864-023-01058-3. Epub 2023 Feb 24. Curr Treat Options Oncol. 2023. PMID: 36826686 Review.
Small intestine cancer is rare, accounting for approximately 3% of all gastrointestinal malignancies. The most common histological subtypes include adenocarcinoma, neuroendocrine tumours (NETs) and gastrointestinal stromal tumours (GISTs). ...The aim of this article was to …
Small intestine cancer is rare, accounting for approximately 3% of all gastrointestinal malignancies. The most common histological subtypes …
Normal Components and Contaminants.
Dhillon J. Dhillon J. Monogr Clin Cytol. 2020;26:34-41. doi: 10.1159/000455733. Epub 2020 Sep 28. Monogr Clin Cytol. 2020. PMID: 32987395 Review.
The pancreas is a retroperitoneal organ located in the duodenal loop with the posterior wall of the stomach overlying it and the left lobe of the liver lying anteriorly to it. ...In addition to the normal pancreatic cells, it is not uncommon to encounter epithelial cells f …
The pancreas is a retroperitoneal organ located in the duodenal loop with the posterior wall of the stomach overlying it and the left …
808 results